Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB351145

ACBD7 Antibody (08), PE, Novus Biologicals™
SDP

Catalog No. NB351145 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB351145 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB351145 Supplier Novus Biologicals Supplier No. NBP306599PE
Only null left
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

ACBD7 Monoclonal antibody specifically detects ACBD7 in Human samples. It is validated for ELISA

Specifications

Antigen ACBD7
Applications ELISA
Classification Monoclonal
Clone 08
Conjugate PE
Dilution ELISA
Formulation PBS
Gene Alias acyl-CoA binding domain containing 7, acyl-CoA-binding domain-containing protein 7, acyl-Coenzyme A binding domain containing 7, bA455B2.2, FLJ38219, FLJ52263, MGC33893
Host Species Mouse
Immunogen This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human ACBD7 (Uniprot#: Q8N6N7; Met1-Ile88).
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 414149
Target Species Human
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.